✦ LIBER ✦

Cost effectiveness of costimulation modulator in anti-TNF-resistant RA

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PGI6 COST EFFECTIVENESS ANALYSIS OF ANTI

✍ F Xie; G Blackhouse; N Assasi; R Hopkins; K Gaebel; D O'Reilly; JE Tarride; RA G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

PAR10 COST-EFFECTIVENESS AND COST-UTILIT

✍ M Eandi; O Zaniolo; S Iannazzo; L Pradelli 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PMS35 Cost-Effectiveness of Tocilizumab

✍ I. Ertenli 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PSS6 COST-EFFECTIVENESS OF INTERMITTENT

✍ AC Lloyd; JM Webber; M Lebmeier; P Conway; J Warburton 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PMS25 COST-EFFECTIVENESS OF RITUXIMAB (M

✍ R Plisko; J Krzystek; P Rys; M Russel-Szymczyk; M Szkultecka-Debek; K Szamotulsk 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PGI5 COST-EFFECTIVENESS OF NATALIZUMAB I

✍ S Panjabi; T Niecko; SL Hass; L Lacey; MD Spencer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB